Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JPMorgan Chase & Co. (JPM)’s Stock Inches Up Amid Private Bank Layoff News

Page 1 of 2

JPMorgan Chase & Co. (NYSE:JPM)’s private bank announced another round of approximately 100 layoffs, the Wall Street Journal reported on Monday, citing people familiar with the matter. The layoffs are a part of JPMogran’s restructuring strategy regarding its private bank. The decision was announced internally. The source added that the bank fires underperformers every year, and continues to actively hire, as well. JPMorgan’s stock has inched up on the back of the news, slightly offsetting the year-to-date decline, which currently stands at 2.30%. This should be good news for hedge funds that had been bullish on the stock, most of whom maintained their positions during the first quarter.

The 750+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards JPMorgan Chase & Co. (NYSE:JPM). The number of bullish hedge fund positions was cut by three in recent months and a  total of 97 of the hedge funds tracked by Insider Monkey were long this stock at the end of March. However,  the level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as The Coca-Cola Company (NYSE:KO), Anheuser-Busch InBev NV (ADR) (NYSE:BUD), and Alibaba Group Holding Ltd (NYSE:BABA) to gather more data points.

Follow Jpmorgan Chase & Co (NYSE:JPM)
Trade (NYSE:JPM) Now!

To most investors, hedge funds are viewed as slow, old investment vehicles of years past. While there are more than 8000 funds in operation today, We hone in on the moguls of this group, around 700 funds. These investment experts command the lion’s share of the smart money’s total asset base, and by following their best equity investments, Insider Monkey has spotted several investment strategies that have historically beaten the market. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Lansdowne Partners, managed by Alex Snow, holds the largest position in JPMorgan Chase & Co. (NYSE:JPM). Lansdowne Partners has a $1.3706 billion position in the stock, comprising 10.8% of its 13F portfolio. Sitting at the No. 2 spot is Ken Fisher of Fisher Asset Management, with a $866.2 million position; 1.6% of its 13F portfolio is allocated to the company. Other members of the smart money that are bullish include Boykin Curry’s Eagle Capital Management, Edgar Wachenheim’s Greenhaven Associates and Richard S. Pzena’s Pzena Investment Management.

On the following page, we are going to take a look at the funds that chose to unload their positions in JPMorgan Chase during the first three months of 2016.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!